Ets-2 Propagates IL-6 Trans-Signaling Mediated Osteoclast-Like Changes in Human Rheumatoid Arthritis Synovial Fibroblast.
Ets-2 Propagates IL-6 Trans-Signaling Mediated Osteoclast-Like Changes in Human Rheumatoid Arthritis Synovial Fibroblast.
复制标题
DOI:
10.3389/fimmu.2021.746503
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Ahmed S
中科院分区:
文献类型:
--
作者:
Singh AK;Haque M;Madarampalli B;Shi Y;Wildman BJ;Basit A;Khuder SA;Prasad B;Hassan Q;Ouseph MM;Ahmed S
Rheumatoid arthritis synovial fibroblasts (RASFs) contribute to synovial inflammation and bone destruction by producing a pleiotropic cytokine interleukin-6 (IL-6). However, the molecular mechanisms through which IL-6 propels RASFs to contribute to bone loss are not fully understood. In the present study, we investigated the effect of IL-6 and IL-6 receptor (IL-6/IL-6R)-induced trans-signaling in human RASFs. IL-6 trans-signaling caused a significant increase in tartrate-resistant acid phosphatase (TRAP)-positive staining in RASFs and enhanced pit formation by ~3-fold in the osteogenic surface in vitro. IL-6/IL-6R caused dose-dependent increase in expression and nuclear translocation of transcription factor Ets2, which correlated with the expression of osteoclast-specific signature proteins RANKL, cathepsin B (CTSB), and cathepsin K (CTSK) in RASFs. Chromatin immunoprecipitation (ChIP) analysis of CTSB and CTSK promoters showed direct Ets2 binding and transcriptional activation upon IL-6/IL-6R stimulation. Knockdown of Ets2 significantly inhibited IL-6/IL-6R-induced RANKL, CTSB, and CTSK expression and TRAP staining in RASFs and suppressed markers of RASF invasive phenotype such as Thy1 and podoplanin (PDPN). Mass spectrometry analysis of the secretome identified 113 proteins produced by RASFs uniquely in response to IL-6/IL-6R that bioinformatically predicted its impact on metabolic reprogramming towards an osteoclast-like phenotype. These findings identified the role of Ets2 in IL-6 trans-signaling induced molecular reprogramming of RASFs to osteoclast-like cells and may contribute to RASF heterogeneity.
登录
查看更多内容
DOI:
10.1002/art.40504
发表时间:
2018-07
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
Falconer J;Murphy AN;Young SP;Clark AR;Tiziani S;Guma M;Buckley CD
通讯作者:
Buckley CD
影响因子:
--
作者:
Kasperkovitz, PV;Timmer, TCG;Verweij, CL
通讯作者:
Verweij, CL
影响因子:
4.8
作者:
Franchimont, N;Rydziel, S;Canalis, E
通讯作者:
Canalis, E
DOI:
10.4161/jkst.25763
发表时间:
2013-10-01
期刊:
JAK-STAT
影响因子:
--
作者:
Kojima H;Inoue T;Kunimoto H;Nakajima K
通讯作者:
Nakajima K
影响因子:
4.8
作者:
Kapasa ER;Giannoudis PV;Jia X;Hatton PV;Yang XB
通讯作者:
Yang XB